Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,135 | 25,751 | 234 | 48,649 | 59,912 |
| Cost of Goods | 1,499 | 1,185 | 261 | 20,590 | 22,471 |
| Gross Profit | -364 | 24,566 | -27 | 28,059 | 37,441 |
| Operating Expenses | 52,328 | 23,324 | 17,551 | 27,454 | 60,361 |
| Operating Income | -52,193 | 1,427 | -17,317 | 1,195 | -22,449 |
| Interest Expense | 535 | 1,071 | 1,239 | 4,064 | 4,654 |
| Other Income | 198 | 51 | -130 | 746 | 165 |
| Pre-tax Income | -52,530 | 407 | -18,686 | -2,123 | -26,938 |
| Income Tax | -740 | -1,308 | -1,150 | 960 | -297 |
| Net Income Continuous | -51,790 | 1,715 | -17,536 | -3,083 | -26,641 |
| Net Income Discontinuous | -3,084 | -10,348 | 4,537 | N/A | N/A |
| Net Income | $-54,874 | $-8,633 | $-12,999 | $-3,083 | $-26,641 |
| EPS Basic Total Ops | -0.88 | -0.14 | -0.22 | -0.05 | -0.51 |
| EPS Basic Continuous Ops | -0.83 | 0.03 | -0.30 | -0.05 | -0.52 |
| EPS Basic Discontinuous Ops | -0.05 | -0.16 | 0.08 | N/A | N/A |
| EPS Diluted Total Ops | -0.88 | -0.14 | -0.22 | -0.05 | -0.51 |
| EPS Diluted Continuous Ops | -0.83 | 0.03 | -0.30 | -0.05 | -0.52 |
| EPS Diluted Discontinuous Ops | -0.05 | -0.16 | 0.08 | N/A | N/A |
| EBITDA(a) | $2,539 | $40,767 | $-22,473 | $6,757 | $13,829 |